Tianjin Ouerke Pharmaceutical Technology Co., Ltd was established in 2010, with the tenet of "integrity, innovation, and excellence". It is a professional supplier in the field of in vitro diagnosis in China, mainly engaged in immunology and molecular biology technology-based Research and development, production and sales of in vitro diagnostic reagents, and other market diversification services.

After ten years of hard work in research and development, the company has a number of independent products, mainly covering major diseases such as cardiovascular disease, kidney injury, inflammatory infection, etc., which are widely used in hospitals at all levels, community outpatient clinics, clinical testing laboratories, etc., and have achieved market consensus with good reviews.